Clearwater helps you protect your assets while satisfying NAIC, Solvency II, and all future compliance requirements.
Clearwater’s scalable reporting and compliance controls make it easy to handle growing data volumes, complex regulatory demands, and increased operational activity.
Streamline U.S. insurer statutory filings with pre-built schedules and data integration.
Automate EU/UK insurance reporting requirements with scale and accuracy.
Clearwater supports NAIC, Solvency II, and additional regulatory frameworks on a single, unified data and workflow foundation.
Firms can expand regulatory support without deploying separate systems or duplicating compliance processes for each rulebook.
A common platform helps compliance, finance, risk, and operations teams work from consistent data and controls.
Investment data is consolidated to reduce manual aggregation and reconciliation across reporting cycles.
Consistent checks and controls help identify issues earlier and improve confidence in investment regulatory compliance outputs.
Clear audit trails supports reviews, examinations, and audits without extensive manual reconstruction.
Clearwater is designed to support changing investment regulatory compliance requirements across jurisdictions and regimes.
A scalable platform model limits disruption when investment regulatory compliance regulations change or new requirements are introduced.
Firms can maintain investment regulatory compliance over time without rebuilding their compliance infrastructure.
Walk through regulatory reporting, controls, and workflows with a Clearwater expert.
Despite market swings in 2026, the S&P 500’s trailing three-year annualized return reached 20%. Our Research Desk looks at how US insurers are shifting equity strategies during the rally.
Trends from the Insurance Investment Outsourcing Report
Insurance risk regulation has quietly changed shape. The frameworks that rating agencies and regulators apply to insurers no longer accept a simplified estimate of what a portfolio would be worth under stress. Increasingly, they expect insurers to demonstrate a genuinely recalculated value — every instrument, repriced under each prescribed condition.